NCT05486897View on ClinicalTrials.gov

Periventricular White Matter Hyperintensities in Cerebral Amyloid Angiopathy and Hypertensive Arteriopathy

CompletedOBSERVATIONAL

Enrollment

315

Participants

Timeline

Start Date

September 5, 2022

Primary Completion Date

December 15, 2023

Study Completion Date

December 15, 2023

Conditions

Cerebral Amyloid AngiopathyHypertensive Arteriopathy

Interventions

OTHER

None, pure observational study

None, pure observational study

Trial Locations (1)

30029

CHU de Nîmes, Nîmes

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nīmes

OTHER